These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32038957)
41. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299 [TBL] [Abstract][Full Text] [Related]
42. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Cui Y; Zhou Z; Chai Y; Zhang Y J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313 [TBL] [Abstract][Full Text] [Related]
43. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis. Zhou L; Ye J; Wen F; Yu H Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950 [TBL] [Abstract][Full Text] [Related]
44. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment. Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N Front Genet; 2021; 12():706661. PubMed ID: 34712264 [No Abstract] [Full Text] [Related]
45. Immune Infiltration Landscape in Clear Cell Renal Cell Carcinoma Implications. Wang Y; Yin C; Geng L; Cai W Front Oncol; 2020; 10():491621. PubMed ID: 33665156 [TBL] [Abstract][Full Text] [Related]
46. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma. Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187 [TBL] [Abstract][Full Text] [Related]
47. Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma. Zhang L; Zhang M; Wang L; Li J; Yang T; Shao Q; Liang X; Ma M; Zhang N; Jing M; Song R; Fan J Front Oncol; 2021; 11():694664. PubMed ID: 34900664 [TBL] [Abstract][Full Text] [Related]
48. Metabolic genes, a potential predictor of prognosis and immunogenicity of clear cell renal cell carcinoma. Ji CJ; Wei XY; Yao LY; Wang YC; Cong R; Song NH Am J Cancer Res; 2023; 13(4):1387-1406. PubMed ID: 37168330 [TBL] [Abstract][Full Text] [Related]
49. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664 [TBL] [Abstract][Full Text] [Related]
50. Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery. Shapiro DD; Lozar T; Cheng L; Xie E; Laklouk I; Lee MH; Huang W; Jarrard DF; Allen GO; Hu R; Kinoshita T; Esbona K; Lambert PF; Capitini CM; Kendziorski C; Abel EJ Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339231 [TBL] [Abstract][Full Text] [Related]
51. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment. Dong X; Gu DN; Wang O; Ye Z Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301 [TBL] [Abstract][Full Text] [Related]
52. Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy. Xiang Z; Shen E; Li M; Hu D; Zhang Z; Yu S Bioengineered; 2021 Dec; 12(1):1773-1790. PubMed ID: 34002666 [TBL] [Abstract][Full Text] [Related]
53. FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma. Lv Z; Cui B; Huang X; Feng HY; Wang T; Wang HF; Xuan YD; Li HZ; Ma X; Huang Y; Zhang X Front Oncol; 2021; 11():756843. PubMed ID: 34956878 [TBL] [Abstract][Full Text] [Related]
54. Decreased Chen Z; Lv Y; He L; Wu S; Wu Z Front Mol Biosci; 2021; 8():657672. PubMed ID: 35096961 [No Abstract] [Full Text] [Related]
55. DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts. Ha M; Jeong H; Roh JS; Lee B; Han ME; Oh SO; Sohn DH; Kim YH Urol Oncol; 2019 Oct; 37(10):735-741. PubMed ID: 31377166 [TBL] [Abstract][Full Text] [Related]
56. Identification of an independent immune-genes prognostic index for renal cell carcinoma. Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413 [TBL] [Abstract][Full Text] [Related]
57. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688 [TBL] [Abstract][Full Text] [Related]
58. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma. Gu YY; Chen G; Lin P; Cheng JW; Huang ZG; Luo J; Zhai GQ; Wang YL; Yan HB; Li SH Cancer Biomark; 2020; 27(2):265-275. PubMed ID: 31929144 [TBL] [Abstract][Full Text] [Related]
59. Ma T; Meng L; Wang X; Tian Z; Wang J; Liu X; Zhang W; Zhang Y Am J Transl Res; 2021; 13(10):11048-11064. PubMed ID: 34786042 [TBL] [Abstract][Full Text] [Related]
60. GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC). Wu HH; Yan X; Chen Z; Du GW; Bai XJ; Tuoheti K; Liu TZ Cancer Cell Int; 2021 Jul; 21(1):354. PubMed ID: 34229684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]